<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 27 Jan 2026 02:17:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p id=&quot;temp_ReleaseStart&quot;&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 27, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,&quot;&lt;/b&gt; &lt;b&gt;says Mattias Perjos, President &amp;amp; CEO at &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to &lt;span value=&quot;Stockholm:GETIB&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge's&lt;/span&gt; performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Q4+and+Full-Year+Report+2025%3A+Organic+growth+and+solid+cash+flow+to+end+the+year/25894925.html</guid>
   <pubDate>Tue, 27 Jan 2026 02:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins</title>
   <link>http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Jan. 28, 2025&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;b&gt;&quot;In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions&quot;, says Mattias Perjos, CEO of &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt;.&lt;/b&gt;&lt;/p&gt;

&lt;p&gt;Growth was particularly strong in ventilators, where &lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; is benefiting from the consolidation in the market. Furthermore, consumables in ECLS in Acute Care Therapies and Sterile Transfer in Life Science, showed solid performance. &lt;/p&gt;
&lt;p&gt;&lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, which was acquired in Q3 2024, reported impressive growth in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Getinge+Year+End+Report+2024%3A+Strong+order+intake+and+increased+sales+contributed+to+sharp+improvement+in+margins/24256765.html</guid>
   <pubDate>Tue, 28 Jan 2025 09:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge completes the acquisition of Paragonix Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+completes+the+acquisition+of+Paragonix+Technologies/23711547.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;b&gt;&lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; has today completed the previously announced acquisition of 100% of the shares of &lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Sept. 11, 2024&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- On &lt;chron&gt;August 22, 2024&lt;/chron&gt;, Getinge announced that it had entered into an agreement to acquire &lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, a leading &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; company in organ transport products and services, for a total purchase price estimated at &lt;money&gt;USD 477 million&lt;/money&gt;, including upfront and currently estimated earn-outs.&lt;/p&gt;

&lt;p&gt;All conditions for the transaction have now been fulfilled, whereupon the transaction was completed today.&lt;/p&gt;
&lt;p&gt;&lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; paid approximately &lt;money&gt;USD 253 million&lt;/money&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+completes+the+acquisition+of+Paragonix+Technologies/23711547.html</guid>
   <pubDate>Wed, 11 Sep 2024 09:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge completes the acquisition of Paragonix Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+completes+the+acquisition+of+Paragonix+Technologies/23711547.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;b&gt;&lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; has today completed the previously announced acquisition of 100% of the shares of &lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Sept. 11, 2024&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- On &lt;chron&gt;August 22, 2024&lt;/chron&gt;, Getinge announced that it had entered into an agreement to acquire &lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, a leading &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; company in organ transport products and services, for a total purchase price estimated at &lt;money&gt;USD 477 million&lt;/money&gt;, including upfront and currently estimated earn-outs.&lt;/p&gt;

&lt;p&gt;All conditions for the transaction have now been fulfilled, whereupon the transaction was completed today.&lt;/p&gt;
&lt;p&gt;&lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; paid approximately &lt;money&gt;USD 253 million&lt;/money&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+completes+the+acquisition+of+Paragonix+Technologies/23711547.html</guid>
   <pubDate>Wed, 11 Sep 2024 09:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
  <item>
   <title>Getinge completes the acquisition of Paragonix Technologies</title>
   <link>http://www.streetinsider.com/Press+Releases/Getinge+completes+the+acquisition+of+Paragonix+Technologies/23711547.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;

&lt;p&gt;&lt;b&gt;&lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; has today completed the previously announced acquisition of 100% of the shares of &lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/se..gotnbg&quot; idsrc=&quot;xmltag.org&quot; &gt;GOTHENBURG, Sweden&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;Sept. 11, 2024&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- On &lt;chron&gt;August 22, 2024&lt;/chron&gt;, Getinge announced that it had entered into an agreement to acquire &lt;span&gt;Paragonix Technologies, Inc.&lt;/span&gt;, a leading &lt;location value=&quot;LC/us&quot; idsrc=&quot;xmltag.org&quot; &gt;U.S.&lt;/location&gt; company in organ transport products and services, for a total purchase price estimated at &lt;money&gt;USD 477 million&lt;/money&gt;, including upfront and currently estimated earn-outs.&lt;/p&gt;

&lt;p&gt;All conditions for the transaction have now been fulfilled, whereupon the transaction was completed today.&lt;/p&gt;
&lt;p&gt;&lt;span value=&quot;OTC-PINK:GNGBY&quot; idsrc=&quot;xmltag.org&quot; &gt;Getinge&lt;/span&gt; paid approximately &lt;money&gt;USD 253 million&lt;/money&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Getinge+completes+the+acquisition+of+Paragonix+Technologies/23711547.html</guid>
   <pubDate>Wed, 11 Sep 2024 09:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31118475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GETIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GNGBY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00619334</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00620424</category>
   	  </item>
 </channel>
</rss>
